Emily O'donnell
About Emily O'donnell
Emily O'Donnell is the Senior Manager of Global Apheresis Compliance at Bristol Myers Squibb in Austin, Texas. She has a diverse background in quality assurance and compliance within the biotechnology field and has received recognition for her contributions to the industry.
Title
Emily O'donnell currently holds the position of Senior Manager, Global Apheresis Compliance at Bristol Myers Squibb, based in Austin, Texas.
Current Role at Bristol Myers Squibb
Emily is the Senior Manager of Global Apheresis Compliance at Bristol Myers Squibb. In this role, she oversees compliance protocols related to apheresis processes on a global scale. Her responsibilities include ensuring that the company meets international regulatory standards, implementing new compliance strategies, and monitoring ongoing compliance activities.
Professional Experience
Emily has held several key positions in the field of quality assurance and compliance. Prior to her current role, she worked as a Specialist in Global Apheresis Compliance at Bristol Myers Squibb from 2020 to 2021. Earlier, she served as a Quality Assurance Biologist at Signature Science, LLC for six years, and as a Quality Assurance Specialist at Michigan Blood for three years. Emily also gained laboratory experience at Amway, working as a Lab Coordinator and Lab Technician.
Education and Expertise
Emily completed her Bachelor of Science (B.S.) in Cell/Cellular and Molecular Biology at Grand Valley State University. She also pursued Wine Studies at Apicius Culinary Institute. Her academic background in cellular and molecular biology forms the basis of her expertise in biotechnology and compliance.
Achievements and Contributions
In her current role, Emily implemented a new protocol that improved the efficiency of apheresis processes by 15%. She received the 'Excellence in Compliance' award at Bristol Myers Squibb in 2022. Emily also published an article in the Journal of Clinical Apheresis on the impact of regulatory changes on global apheresis practices and presented at the 2022 Apheresis Conference on global compliance standards. Additionally, she volunteers as a mentor for young professionals in the biotechnology field.